SCHEMBL855086

SCHEMBL855086

CCCCCNc1nc(C)c(Cc2ccc(OCCCCl)cc2)c(N)n1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.47
TLR7 Q9NYK1 14/20 0.45
PKM P14618 1/20 0.44
TLR8 Q9NR97 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854804 0.89 TLR7 (0.55) DHFRTLR7PKMTLR8
SCHEMBL853213 0.89 TLR7 (0.57) DHFRTLR7PKMTLR8
SCHEMBL854178 0.87 ALDH1A1 (0.51) DHFRTLR7TLR8
SCHEMBL853436 0.85 TLR7 (0.54) TLR7
SCHEMBL861355 0.85 TLR7 (0.56) TLR7TLR8
SCHEMBL861830 0.85 TLR7 (0.60) TLR7TLR8
SCHEMBL854279 0.83 DHFR (0.45) DHFRTLR7TLR8
SCHEMBL16568672 0.83 TLR7 (0.66) TLR7TLR8
SCHEMBL853346 0.82 TLR7 (0.47) DHFRTLR7TLR8
SCHEMBL19056441 0.81 DHFR (0.41) DHFRTLR7PKMTLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432768-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES AstraZeneca AB (SE) 2012-03-28 EP disclosed
WO-2010133885-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES ASTRAZENECA AB (SE) 2010-11-25 WO disclosed